1. National Management of Hospital Pharmaceuticals and Medical Devices Andrew Davies Acting Manager, Funding & Procurement

2. Background Ministerial Review Group advocated improved prioritisation in health funding decisions Different levels of access across country There is limited resource, and choices need to be made Cabinet asked PHARMAC to:  expand its role to include all hospital pharmaceuticals  work with MoH and others to develop a national plan for medical devices

3. Hospital Medicines Hospital Pharmaceuticals Subcommittee Hospital Pharmaceuticals Subcommittee Specialist Subcommittee Colleges DHB Hospitals PTAC Consultation with wider sector

5. Medical Devices Number of challenges No baseline Clinical advice structures? Health Benefits Limited working with District Health Boards to develop national data collection PHARMAC looking at insulin pumps as a test case

6. Summary PHARMAC is developing a national list of hospital medicines Evidence based Clinical input important Aims to improve consistency of access across DHBs Medical Devices Understanding where we are now is critical Information systems being improved National plan later this year

7. Table Discussion How can you manage the tension between clinical/patient choice and value for money when funding is limited? Do you think this is different for hospital pharmaceuticals and medical devices, and why?